Patents
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
12/2005
12/14/2005EP1296669B1 Combination preparation consisting of omega-3-fatty acids and of conjugated linoleic acids for treating immunologically oriented clinical signs
12/14/2005EP0832255B1 Recombinant bacterial system with environmentally limited viability
12/14/2005CN1708316A Method for inhibiting yeast growth
12/14/2005CN1708315A Anti-tumor combinations comprising proteins and chemotherapeutics
12/14/2005CN1708311A Remedy for fibromyalgia
12/14/2005CN1706955A Construction and application of oncolytic adenovirus recombinant of tumor cell specifically expressing immunoregulation factor GM-CSF
12/14/2005CN1706939A Antinuclear polyhedron virus transgenic silkworm and generating method thereof
12/14/2005CN1706479A Methods and compositions for accelerating alcohol metabolism
12/14/2005CN1706402A Health food composition containing stomach inclusion of sucking river deer and its prepn process
12/14/2005CN1706401A Medicine composition containing stomach inclusion of sucking river deer and its prepn process
12/14/2005CN1706400A Application of stomach inclusion of sucking river deer in preparing medicine
12/14/2005CN1706399A Application of stomach inclusion of sucking river deer in producing health food
12/14/2005CN1706398A Drying material and producing method thereof
12/14/2005CN1231589C Eukaryotic gene expression cassette and uses thereof
12/14/2005CN1231573C Lawsonia intracellularis cultivation, anti-lawsonia intracellularis vaccines and diagnostic agents
12/14/2005CN1231257C Use of preparing medicine for raising genitality of female animals with long PENTRAXIN PTX 3
12/14/2005CN1231227C Making process of nanometer level pearl powder and shell powder
12/13/2005US6974796 Therapeutic compositions for treatment of a damaged tissue
12/13/2005US6974795 Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
12/13/2005US6974594 Method of preparing biological materials and preparations produced using same
12/13/2005US6974571 Isolated stromal cells and methods of using the same
12/08/2005WO2005116194A1 Method of culturing myoblst or myoblast-like cell for forming myofiber in vitro
12/08/2005WO2005116193A1 Procedure for the growing of live tissue in a living organism
12/08/2005WO2005116192A2 Genetically engineered cells for therapeutic applications
12/08/2005WO2005116191A1 Method of culturing embryonic stem cells with the use of amniotic membrane-origin factor
12/08/2005WO2005116188A1 Lactic acid bacteria with immunoregulating activities
12/08/2005WO2005115491A1 Implantable biomaterial and method for the preparation thereof
12/08/2005WO2005115476A1 Drug comprising as the active ingredient proliferative vector containing survivin promoter
12/08/2005WO2005115469A2 Estrogen modulation of ifn-gamma-mediated conditions and diseases
12/08/2005WO2005115420A1 A composition having immunoregulating activities comprising lactobacillus pentosus
12/08/2005WO2005115419A1 USES OF BISPECIFIC ANTIBODY (Biab) COATED DENDRITIC CELLS PULSED WITH ANTIGENS
12/08/2005WO2005115367A2 Modulation of neurotransmitter activity in neurons
12/08/2005WO2005095590A3 Sperm suspensions for sorting into x or y chromosome-bearing enriched populations
12/08/2005WO2005089411A3 Tissue products from animals lacking functional alpha 1,3 galactosyl transferase
12/08/2005WO2005081964A3 Topical delivery of a nitric oxide donor to improve body and skin appearance
12/08/2005WO2005081649A3 Preparation for reducing protein deficiency in an organism and method for the production thereof
12/08/2005WO2005054447A3 Müller stem cells
12/08/2005WO2005001054A3 Methods of producing neurons
12/08/2005WO2004069172A3 Multilineage-inducible cells and uses thereof
12/08/2005US20050272694 Composition containing beta-glucan and constipation-relieving drug, immunopotentiatior, and skin moistening agent using the composition
12/08/2005US20050272161 Fixed-dried red blood cells or blood platelets carrying an active agent which, upon reconstitution, adhere to thrombogenic surfaces, undergo shape change, form a hemostatic plug, and release their granular contents
12/08/2005US20050272156 Utilizes one or more sets of electrodes spaced to hold surface tension of sample receiving pulses; for gene discovery/therapy/tissue engineering
12/08/2005US20050272151 Dendritic cell line
12/08/2005US20050272149 Therapeutic delivery of adenosine into a tissue
12/08/2005US20050272148 Method of collecting placental stem cells
12/08/2005US20050272147 Methods for ex vivo propagation of somatic hair follicle stem cells
12/08/2005US20050271758 Topical compositions containing Bacillus coagulans extracellular products and uses thereof
12/08/2005US20050271751 Active principle which is capable of inducing the conversion of inactive TGFb-latent into active TGFb
12/08/2005US20050271739 Methods and compositions for accelerating alcohol metabolism
12/08/2005US20050271738 Methods and compositions for treating tissue defects using pulsed electromagnetic field stimulus
12/08/2005US20050271690 Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
12/08/2005US20050271674 Methods and compositions for modulating the immune system of animals
12/08/2005US20050271646 Fibrin material and method for producing and using the same
12/08/2005US20050271643 Bacterial strains, compositions including same and probiotic use thereof
12/08/2005US20050271641 Method for improved breast milk feeding to reduce the risk of allergy
12/08/2005US20050271640 Method for inhibiting yeast growth
12/08/2005US20050271639 Genetically engineered cells for therapeutic applications
12/08/2005US20050271634 Growth factor therapy mobilization of stem cells into the peripheral blood
12/08/2005US20050271633 Issue defect augmentation and repair with in vitro cultured fibroblasts
12/08/2005US20050271632 Methods of modulating hair growth
12/08/2005US20050271631 Material compositions and related systems and methods for treating cardiac conditions
12/08/2005US20050271630 Method for treating cancer
12/08/2005US20050271628 Negative-sense RNA virus vector for nerve cell
12/08/2005US20050271624 Use of apoptosis inducing agents in the treatment of (auto) immune diseases
12/08/2005US20050271622 Construct of tumor-selective recombinant adenovirus, method for preparing the same and use thereof
12/08/2005US20050271621 Ablated slam-dependent entry
12/08/2005US20050271620 Herpes simplex virus complex
12/08/2005US20050271604 Matrix protein compositions for wound healing
12/08/2005CA2772033A1 Compositions and methods for bone formation and remodeling
12/08/2005CA2772029A1 Compositions and methods for bone formation and remodeling
12/08/2005CA2568014A1 Lactic acid bacteria with immunoregulating activities
12/08/2005CA2567101A1 Estrogen modulation of ifn-gamma-mediated conditions and diseases
12/08/2005CA2566473A1 Uses of bispecific antibody (biab) coated dendritic cells pulsed with antigens
12/07/2005EP1602379A1 Botulinum toxin B for treating spastic muscle
12/07/2005EP1602377A1 Composition containing beta-glucan and constipation-relieving drug, immunopotentiator and skin moistening agent using the composition
12/07/2005EP1602284A1 Method of producing fractions containing a high concentration of milk basic cystatin and decomposition products thereof
12/07/2005EP1601763A2 Cell culture
12/07/2005EP1601759A2 Expansion of renewable stem cell populations using modulators of pi 3-kinase
12/07/2005EP1601390A2 Scaffold for cell growth and differentiation
12/07/2005EP1601376A1 Use of myxoma virus for therapeutic treatment of cancer and chronic viral infection
12/07/2005EP1601371A2 Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver components
12/07/2005EP1601368A2 Methods and compositions for treatment of viral diseases
12/07/2005EP1601333A2 Novel insertion sites in pox vectors
12/07/2005EP1601248A2 Use of umbilical cord blood to treat individuals having a disease, disorder or condition
12/07/2005EP1578983A3 Methods for regulating co-stimulatory molecule expression with reactive oxygen
12/07/2005EP1425381A4 Emu-based formulations for wound treatment related application information
12/07/2005EP1252323B1 Virus strains for the oncolytic treatment of cancer
12/07/2005EP1178812B1 Methods of making conditioned cell culture medium compositions
12/07/2005EP0922105B1 Infectious papillomavirus pseudoviral particles
12/07/2005EP0831901B2 Vaccine comprising a polysaccharide antigen-carrier protein conjugate and free carrier protein
12/07/2005EP0697893B1 Neural thread protein gene expression and detection of alzheimer's disease
12/07/2005CN1705744A Transplantable cell
12/07/2005CN1705490A Plasma preparation or serum preparation and process for producing the same
12/07/2005CN1705489A Clinical application of dendritic cell-based cancer immunotherapy
12/07/2005CN1230539C Bacterial auto-inducer inactivation protein, its coded nucleic acid molecule and uses
12/07/2005CN1230533C Quiescent cell populations for nuclear transfer
12/07/2005CN1230206C Polymer blends as biodegradable matrices for preparing biocomposites
12/07/2005CN1230204C Method of immunomodulation by means of adoptive transfer of antigernspecific cytotoxic T-cells
12/07/2005CN1230184C Prepns. for immunotherapy for cancer having bacterial somatic constituent as active ingredient
12/07/2005CN1230183C Dictyoptera grease prepared healthcare food